Deal Flow Quality vs Quantity: What the VC Data Says

Key Takeaways

Quality and quantity answer different questions: One is about your deal funnel, the other is about how many checks you write, and conflating them is why this debate never ends.
At seed, more shots tend to win: AngelList data on 10,000+ investors shows returns rise roughly 9 basis points for every additional company added to a portfolio.
At later stages, conviction tends to win: Concentrated managers who back fewer companies with bigger ownership consistently outperform their more diversified peers.
The power law sets the rules: Because a tiny share of deals drives almost all returns, missing a winner costs far more than backing a loser.
Your edge decides the strategy: Quantity pays when outcomes are unpredictable, quality pays where you actually have an access or information advantage.

Ask ten investors whether deal flow quality or quantity matters more, and you'll get ten confident answers that flatly contradict each other. That's not because some of them are wrong. It's because they're not arguing about the same thing.

One camp points to AngelList data showing that the more startups you back, the better you tend to do. The other points to firms like Benchmark Capital, which has generated billions backing a handful of companies per fund. Both are right. They are just answering two different questions that the word "deal flow" quietly smuggles together.

Two Questions Hiding in One Debate

Deal flow is the volume and quality of investment opportunities an investor sees. Quality deal flow means a pipeline rich in credible, well-matched startups, not just a high count of inbound pitches.

That definition matters because the real fight is never about whether to source good deals. Nobody argues for worse deal flow. The argument is about portfolio construction: once you have a strong funnel, how many of those companies should you actually fund, and how big should each check be?

Keep those two questions separate and the contradiction dissolves. Top-of-funnel quality is non-negotiable for everyone. The quantity debate is really a debate about how many checks to write.

The Case for Quantity

The strongest data for quantity comes from Abe Othman, Head of Data Science at AngelList, whose team studied the portfolios of more than 10,000 limited partners. The finding was blunt: performance increases with the number of investments. The regression came out to roughly 9 basis points of additional annual return for each company added to a portfolio, so an investor in 100 startups meaningfully outperformed one who backed just a few.

The reason is the power law. As the data on venture returns shows, the top 10% of deals drive 90% of all gains while most investments return less than the capital put in. When outcomes are that skewed and that hard to predict, your biggest risk is not backing a loser. It is missing the one winner that would have carried the whole fund.

Academic work backs this up. Harvard's William Kerr, Ramana Nanda, and Matthew Rhodes-Kropf framed early-stage investing as "entrepreneurship as experimentation": when each bet is a cheap, high-variance experiment, running more experiments raises your odds of catching the rare outlier. Dave McClure built 500 Startups on exactly this logic, arguing that a high-volume seed portfolio delivers stronger cash-on-cash returns than a concentrated one, as long as you double down on the winners later.

The Case for Conviction

Now the other side, which is just as evidence-backed. Studies of fund performance consistently find that concentrated managers outperform their diversified peers. A diversified portfolio typically means 45 or more companies at less than 5% ownership each. A concentrated one means fewer than 20 companies at 10% or more.

Why does concentration win at later stages? Selection and engagement. Concentrated investors are more selective, spend far more time on diligence, and reportedly devote up to 8 times more hours per founder than spray-and-pray funds. They also own enough of each company for a single home run to actually move the fund. Once a startup has traction and the outcome is more legible, the ability to pick well and own meaningfully starts to beat the ability to simply own more lottery tickets. This is where a sharp framework for evaluating unicorn potential earns its keep.

So Which Wins? Stage and Edge Decide

The honest answer is that it depends on two variables: the stage you invest at, and whether you have a real edge.

Seed stage, low predictability, limited edge: lean quantity. Index broadly into credible deals and let the power law find your winners.
Series A and beyond, more signal, genuine access or expertise: lean quality. Concentrate capital into high-conviction bets where your selection actually adds value.

McClure's own model is the synthesis, not a contradiction: spread bets wide at seed, then concentrate follow-on capital into the breakouts. Y Combinator is the cleanest proof that quality and quantity are not enemies. It funds a large batch every cycle (quantity) but only after brutal selection (quality), then pours follow-on money into the standouts. The result, as the breakdown of YC's unicorn machine explains, is an outlier rate no concentrated boutique has matched.

One limit worth naming: these are averages. AngelList's numbers can't fully capture access, the hidden variable that lets a top firm be both selective and right. More shots only help if every shot still clears your quality bar.

The One Thing Neither Side Can Skip

Whichever strategy you choose, both demand the same underlying skill: telling a credible deal from noise, fast, at scale. Quantity without quality deal flow is just expensive noise. Conviction without it is confidence in the wrong company.

That is fundamentally a screening problem, and it's what Unicorn Screener is built to solve. By scoring startups on the dimensions research ties to outlier outcomes, market size, founder quality, traction velocity, and competitive position, it lets you widen the funnel without lowering your bar. The public Top 50 leaderboard is a live look at where the highest-scoring candidates currently cluster across every startup screened so far.

What This Means for You

Separate the two decisions. Deal flow quality is mandatory for everyone. Portfolio size is the actual choice you're making.
At seed, widen the funnel. When outcomes are unpredictable, more credible shots beat fewer confident ones.
At Series A and later, concentrate. Where you have real edge, conviction and ownership outperform diversification.
Never trade away deal-flow quality for volume. More bad deals is not a strategy, it's a faster way to lose.
Screen systematically. Score any startup to keep your bar high while you scale your shots.

Want to screen startups like a top-tier VC? Score any startup for free with our research-backed evaluation model.